| Catalog Number |
MX61260 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Hemorrhage/Blood Loss/Bleeding (1888)
|
| Date of Event |
07/13/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
As reported in the move study, a patient experienced ecchymosis, pain and bleeding after the use of three 6-12f mynx control venous vascular closure devices (vcd).Bleeding required transfusion, surgical intervention, or rehospitalization.The patient was prescribed pain medication to take as needed after discharge.The device was used after an atrial fibrillation (afib) ablation using a non-cordis device.Venous access was obtained with the use of ultrasound with one access site in the right leg and two in the left.A 9f sheath was used in the right groin and a 7f and 10f were used in the left.The devices were successfully deployed.The patient received 15000 units of intraprocedural heparin and 100mg of protamine was administered.The activated clotting time (act) was 331 seconds.Procedural time was 64 minutes, and time to ambulation was approximately two hours.The device was stored and prepped according to the ifu.The deployer was trained in the use of the device.The devices will not be returned for evaluation.
|
| |
|
Additional Manufacturer Narrative
|
|
Due to system limitations, section h6 required to input type of investigation, investigation findings, and investigation conclusions for an initial report.Pending additional information to complete investigation.Additional information is pending and will be submitted within 30 days upon receipt.
|
| |
|
Search Alerts/Recalls
|